Kiniksa Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Go back to Kiniksa Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
(NASDAQ: KNSA) Delayed: 77.24 -2.09 (2.63%)
Previous Close $79.33    52 Week High
Open $78.95    52 Week Low
Day High $79.61    P/E N/A 
Day Low $76.99    EPS
Volume 1,058,201